The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Ambulatory Blood Pressure Monitoring

William White

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Scripps Health

M. Budoff

Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Recent Cholesterol Guidelines and Integration into Clinical Practice

The North American Thrombosis Forum (NATF)

J. Plutzky, L. Braun, J. Ross

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

MAFLD: What Is It?

Houston Methodist

D. Victor

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

Incretin-based Therapies in the Management of Obesity and its Comorb…

Michigan Medicine

A. Rothberg

Tirzepatide Updates

Diana Isaacs